Good Lifestyle

Now there is both clinical and real evidence that showget vaccinated for COVID-19 offers you a lot of protection against the virus. After all, the blows have radically reduced infections in the United States andcut up case numbers at their lowest levels since the first days of the pandemic. But if you are one of the millions of Americans who rely on certain types of drugs to help a continuous health issue, research says there is a chance that you may not have the Antibody you need to protect you from COVID-19 post-vaccine.

A great study published in the medical newspaperCancer cell On June 5 decisive to determine how current Covid-19 vaccines are currently available for cancer patients. The researchers used data of 200 patients eligible for the Montefiore and Albert Einstein College of Medicine in New York by testing their antibody levels after being fully vaccinated. The results revealed that most patients with study cancer responded well to fire, 30% of theseTake immunosuppressive drugs There was no sign of seroconversion, which is the medical term for the production of antibodies in response to a virus.

RELATED:Half of the people who did it that did not have an antibodies after vaccination, the study says.

The results add toProof of assembly that the six million Americans who rely on drugs such as methotrexate, rituxan and certain steroids that suppress the immune system - which can be used to treat certain cancers, arthritis, psoriasis and aspire to the rejection of the transplants of Organs - do not see the complete effectiveness of their CVIV-19 vaccines after regular doses. He also added fuel to the argument that additional doses should beadministered to immunocompromised persons to resort to their immune response.

"It should already exist a national study by looking at post-transplant patients to get reminder fire"Halmos balazs, MD, an oncologist at the Montefore Medical Center in New York and the main author of the study, saidThe New York Times. "It should not be our little team here in the Bronx trying to understand that."

The use of aShot of planned booster For such patients is already practical in countries such as France. A study found that, although only 40% of immunocompromised patients had antibodies after two doses, it was increased to 68% four weeks after administration of a third shot.

RELATED:If you had a vaccine, get a reminder now, the virus expert warns.

While Moderna and Pfizer are eachPlanning studies on the use of aThird dose in immunocompromised patientsSome researchers argue that the slow pace of federal agencies makes it difficult for the creation of vital information. "It's a very simple study"Jose U. Scher, MD, a rheumatologist in Nyu Langone Health who led a study on the effect of methotrexate on vaccines, saidThe temperature. "There is no rocket science here."

For the moment, the American Centers for Disease Control and Prevention (CDC) advise that "The antibody test is not recommended Evaluate immunity to SARS-COV-2 as a result of Covid-19 vaccination "as results may not be precise or useful. The agency also says that" at that time, the revocation is not Recommended after people who received COVID-19 vaccines during chemotherapy or treatment with other immunosuppressive drugs finds immune skills, "adding that their recommendations on additional shots may change when more information will be available.

RELATED:If you have modern, here's how your antibodies meet the delta variant.